DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Patanol (Olopatadine Hydrochloride) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

PATANOL SUMMARY

PATANOL® (olopatadine hydrochloride ophthalmic solution) 0.1% is a sterile ophthalmic solution containing olopatadine, a relatively selective H1- receptor antagonist and inhibitor of histamine release from the mast cell for topical administration to the eyes.

PATANOL (olopatadine hydrochloride ophthalmic solution) 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis.


See all Patanol indications & dosage >>

PATANOL NEWS HIGHLIGHTS

Published Studies Related to Patanol (Olopatadine)

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. [2008.07.08]

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye. [2008.02]

Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge. [2007.12]

Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. [2006.05]

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. [2005.12]

more >>

Clinical Trials Related to Patanol (Olopatadine)

Mast-Cell Stabilizing Effects of Olopatadine [Completed]

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis [Completed]

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [Completed]

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Recruiting]

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Recruiting]

more >>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008